Angiogenic profile of breast carcinoma determines leukocyte infiltration

Clinical Cancer Research

Volumn 10, Issue 21, 2004, Pages 7171-7178

  Bouma Ter Steege, Jessica C A ^a   Baeten, Coen I M ^a   Thijssen, Victor L J L ^a   Satijn, Sietske A ^a   Verhoeven, Inge C L ^a   Hillen, Harry F P ^a   Wagstaff, John ^a   Griffioen, Arjan W ^a  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOPOIETIN 1; ANGIOPOIETIN 2; ANGIOPOIETIN 4; BASIC FIBROBLAST GROWTH FACTOR; BETA ACTIN; CD16 ANTIGEN; CD3 ANTIGEN; CD31 ANTIGEN; CD4 ANTIGEN; CD45 ANTIGEN; CD68 ANTIGEN; CD8 ANTIGEN; CELL ADHESION MOLECULE; COMPLEMENTARY DNA; CYCLOPHILIN A; INTERCELLULAR ADHESION MOLECULE 1; UNCLASSIFIED DRUG; VASCULOTROPIN A; VASCULOTROPIN C; VASCULOTROPIN D;

ADULT; ANGIOGENESIS; ARTICLE; BREAST CARCINOMA; CLINICAL ARTICLE; DNA SYNTHESIS; ENDOTHELIUM CELL; FEMALE; FLOW CYTOMETRY; FLUORESCENCE ACTIVATED CELL SORTING; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFLAMMATORY INFILTRATE; INTRADUCTAL CARCINOMA; LEUKOCYTE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UMBILICAL VEIN;

ANTIGENS, CD45; BREAST NEOPLASMS; CARCINOMA; CELL SEPARATION; CELLS, CULTURED; DNA PRIMERS; DNA, COMPLEMENTARY; DOWN-REGULATION; ENDOTHELIUM, VASCULAR; FEMALE; FLOW CYTOMETRY; HUMANS; IMMUNOHISTOCHEMISTRY; INTERCELLULAR ADHESION MOLECULE-1; LEUKOCYTES; LYMPHATIC METASTASIS; NEOVASCULARIZATION, PATHOLOGIC; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA; TIME FACTORS; UMBILICAL VEINS; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR C; VASCULAR ENDOTHELIAL GROWTH FACTOR D;

EID: 8444222651     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-04-0742     Document Type: Article

References (30)

1. Zhang L, Conejo-Garcia JR, Katsaros D, et al. Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer. N Engl J Med 2003;348:203-13.
2. Funada Y, Noguchi T, Kikuchi R, Takeno S, Uchida Y, Gabbert HE. Prognostic significance of CD8+ T cell and macrophage peritumoral infiltration in colorectal cancer. Oncol Rep 2003;10:309-13.
3. Fernandez-Acenero MJ, Galindo-Gallego M, Sanz J, Aljama A. Prognostic influence of tumor-associated eosinophilic infiltrate in colorectal carcinoma. Cancer (Phila.) 2000;88:1544-8.
4. Dirkx A, Oude Egbrink MG, Kuipers M, et al. Tumor angiogenesis modulates leukocyte-vessel wall interactions in vivo by reducing endothelial adhesion molecule expression. Cancer Res 2003;63:2322-9.
5. Griffioen AW, Damen CA, Blijham GH, Groenewegen G. Tumor angiogenesis is accompanied by a decreased inflammatory response of tumor associated endothelium. Blood 1996;88:667-73.
6. Tromp SC, Oude Egbrink MG, Dings RPM, et al. Tumor angiogenesis factors reduce leukocyte adhesion in vivo. Int Immunol 2000;12:671-6.
7. Kuzu I, Bicknell R, Fletcher CD, Gatter KC. Expression of adhesion molecules on the endothelium of normal tissue vessels and vascular tumors. Lab Investig 1993;69:322-8.
8. Melder RJ, Koenig GC, Witwer BP, Safabakhsh N, Munn LL, Jain RK. During angiogenesis, vascular endothelial growth factor and basic fibroblast growth factor regulate natural killer cell adhesion to tumor endothelium. Nat Med 1996;2:992-7.
9. Reiss Y, Hoch G, Deutsch U, Engelhardt B. T cell interaction with ICAM-1-deficient endothelium in vitro: essential role for ICAM-1 and ICAM-2 in transendothelial migration of T cells. Eur J Immunol 1998;28:3086-99.
10. Baeten CIM, Wagstaff J, Verhoeven ICL, Hillen HFP, Griffioen AW. Flow cytometric quantification of tumor endothelial cells: an objective alternative for microvessel density assessment. Br J Cancer 2002;87:344-7.
11. Tamiolakis D, Simopoulos C, Cheva A, et al. Immunophenotypic profile of tumor infiltrating lymphocytes in medullary carcinoma of the breast. Eur J Gynaecol Oncol 2002;23:433-6.
12. Yakirevich E, Izhak OB, Rennert G, Kovacs ZG, Resnick MB. Cytotoxic phenotype of tumor infiltrating lymphocytes in medullary carcinoma of the breast. Mod Pathol 1999;12:1050-6.
13. Bloom HJ, Richardson WW, Field JR. Host resistance and survival in carcinoma of breast: a study of 104 cases of medullary carcinoma in a series of 1,411 cases of breast cancer followed for 20 years. Br Med J 1970;3:181-8.
14. Hellwig SMM, Damen CA, Van Adrichem NPH, Groenewegen G, Blijham GH, Griffioen AW. Endothelial CD34 is suppressed in human malignancies; role of angiogenic factors. Cancer Lett 1997;120:203-11.
15. Menard S, Tomasic G, Casalini P, et al. Lymphoid infiltration as a prognostic variable for early-onset breast carcinomas. Clin Cancer Res 1997;3:817-9.
16. Griffioen AW, Damen CA, Martinotti S, Blijham GH, Groenewegen G. Endothelial ICAM-1 expression is suppressed in human malignancies; role of angiogenic factors. Cancer Res 1996;56:1111-7.
17. Griffioen AW, Relou IAM, Gallardo Torres HI, et al. The angiogenic factor bFGF impairs leukocyte adhesion and rolling under flow conditions. Angiogenesis 1999;2:45-50.
18. Guenzi E, Topolt K, Cornali E, et al. The helical domain of GBP-1 mediates the inhibition of endothelial cell proliferation by inflammatory cytokines. EMBO J 2001;20:5568-77.
19. Jeltsch M, Kaipainen A, Joukov V, et al. Hyperplasia of lymphatic vessels in VEF-C transgenic mice. Science (Wash. DC) 1997;276:1423-5.
20. Orlandini M, Marconcini L, Ferruzzi R, Oliviero S. Identification of a c-fos-induced gene that is related to the platelet-derived growth factor/vascular endothelial growth factor family. Proc Natl Acad Sci USA 1996;93:11675-80.
21. Shin HY, Smith ML, Toy KJ, Williams PM, Bizios R, Gerritsen ME. VEGF-C mediates cyclic pressure-induced endothelial cell proliferation. Physiol Genomics 2002;11:245-51.
22. Marconcini L, Marchio S, Morbidelli L, et al. c-fos-induced growth factor/vascular endothelial growth factor D induces angiogenesis in vivo and in vitro. Proc Natl Acad Sci USA 1999;96:9671-6.
23. Leek RD, Hunt NC, Landers RJ, Lewis CE, Royds JA, Harris AL. Macrophage infiltration is associated with VEGF and EGFR expression in breast cancer. J Pathol 2000;190:430-6.
24. Leek RD, Lewis CE, Whitehouse R, Greenall M, Clarke J, Harris AL. Association of macrophage infiltration with angiogenesis and prognosis in invasive breast carcinoma. Cancer Res 1996;56:4625-9.
25. Sivridis E, Giatromanolaki A, Papadopoulos I, Gatter KC, Harris AL, Koukourakis MI. Thymidine phosphorylase expression in normal, hyperplastic and neoplastic prostates: correlation with tumour associated macrophages, infiltrating lymphocytes, and angiogenesis. Br J Cancer 2002;86:1465-71.
26. Vincent-Salomon A, Carton M, Zafrani B, et al. Long-term outcome of small size invasive breast carcinomas independent from angiogenesis in a series of 685 cases. Cancer (Phila.) 2001;92:249-56.
27. Sarbia M, Bittinger F, Porschen R, Dutkowski P, Willers R, Gabbert HE. Tumor vascularization and prognosis in squamous cell carcinomas of the esophagus. Anticancer Res 1996;16:2117-21.
28. Cao Y, Linden P, Farnebo J, et al. Vascular endothelial growth factor C induces angiogenesis in vivo. Proc Natl Acad Sci USA 1998;95:14389-94.
29. Nagy JA, Vasile E, Feng D, et al. Vascular permeability factor/vascular endothelial growth factor induces lymphangiogenesis as well as angiogenesis. J Exp Med 2002;196:1497-506.
30. Williams CS, Leek RD, Robson AM, et al. Absence of lymphangiogenesis and intratumoural lymph vessels in human metastatic breast cancer. J Pathol 2003;200:195-206.